Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESALIT: Lithium Carbonate in TBR1-related Neurocognitive Disorder
NCT06776848Phase 2Recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in TBR1-related neurodevelopmental disorder, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Sep 2025; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
TBR1-related neurodevelopmental disorder
Beyond the preview
Go deeper on NCT06776848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06776848.